Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02885233 · ClinicalTrials.gov registry record · NA

Evaluation of a Web-Based Fall Prevention Program on People With Multiple Sclerosis

A NA study of Multiple Sclerosis, sponsored by Oregon Health and Science University.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT02885233 is a NA study of Multiple Sclerosis that has completed, run by Oregon Health and Science University. The registered enrollment target is 30 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02885233, a NA study of Multiple Sclerosis, has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study evaluates the effectiveness of a web-based fall prevention program called Free From Falls Online (FFFO) on people with multiple sclerosis.

Conditions Studied

Interventions

  • BEHAVIORAL Waitlist Control
  • BEHAVIORAL Free From Falls Online

Study Locations (1)

Oregon

  • Oregon Health Sciences University - Portland

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2017-02-15
Est. Completion 2018-01-25
Phase NA

What the Registry Record Tells You About NCT02885233

The ClinicalTrials.gov registry entry for NCT02885233 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (95% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Waitlist Control is the first listed.

NCT02885233 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT02885233 about?

NCT02885233 is a clinical study titled "Evaluation of a Web-Based Fall Prevention Program on People With Multiple Sclerosis". This study evaluates the effectiveness of a web-based fall prevention program called Free From Falls Online (FFFO) on people with multiple sclerosis.

What is the current status of trial NCT02885233?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-02-15. Estimated completion is 2018-01-25.

What conditions does trial NCT02885233 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT02885233?

The interventions under investigation include: Waitlist Control (BEHAVIORAL), Free From Falls Online (BEHAVIORAL).

Who is sponsoring clinical trial NCT02885233?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02885233 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.